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Mal de Meleda is a rare form of palmoplantar kerato-
derma, and recently mutations in the ARS (compo-
nent) B gene have been identi¢ed in families with this
disease. We identi¢ed a recurrent nonsense mutation,
R96X, in four families of Turkish descent. In this re-
port, we demonstrate that these families share a com-
mon ancestral haplotype at the mal de Meleda locus, sug-
gesting a founder e¡ect. Key words: ARS (component B)/
founder/mal de Meleda/mutation/SLURP-1. J Invest Dermatol
120:967 ^969, 2003
M
al de Meleda (MdM) (keratosis palmoplantaris
transgrediens, MIM# 248300) is a rare form of
palmoplantar keratoderma inherited in an auto-
somal recessive manner. It is characterized by
erythema and hyperkeratosis of the palms and
soles, extending to the dorsal aspects of the hands and feet
(known as transgrediens palmoplantar keratoderma) (Hovorka
and Ehlers, 1897; Schnyder et al, 1969). Some of the commonly
associated ¢ndings include nail abnormalities, keratotic plaques
over the joints, perioral erythema, brachydactyly, and pseudoain-
hum (Bergman et al, 1993). MdM was originally described and
thus was thought to originate from the leper colonies living on
the Adriatic island of Meleda, now Mljet in Croatia. MdM is not
limited to Croatia and the island of Mljet, however. Indeed,
families with MdM have been described in various European
countries, as well as in the USA, northern Africa, the Middle East,
and the Far East (Jee et al, 1985; Bergman et al, 1993; Chotzen et al,
1993; Urbina et al, 1995; Lestringant et al, 1997; Ayman et al, 2000).
The disease locus has been mapped to chromosome 8qter
(Fischer et al, 1998), and in recent studies homozygous mutations
in the ARS (component B) gene (ARS) have been identi¢ed in
families with this disorder (Fischer et al, 2001;Ward et al, 2003). In
this report, we describe three unrelated families of Turkish
descent in which a homozygous nonsense mutation in the ARS
gene was identi¢ed. Haplotype analysis with markers £anking
the ARS gene on chromosome 8qter was performed in these
three families and in one family we reported previously with
the same mutation (Ward et al, 2003). The analysis revealed that
the a¡ected individuals in these families shared a common ances-
tral haplotype at the MdM locus, suggesting a founder e¡ect. Of
interest, this mutation, R96X, has previously been reported in
three families from Croatia (Fischer et al, 2001). Three of our fa-
milies live in the villages of Isparta and one in Antalya, both lo-
cated in southernTurkey.Thus, it is possible that individuals with
the R96X mutation relocated from Croatia, perhaps from the
Meleda island, to southern Turkey carrying the mutation with
them to this region.
Genomic DNA was extracted from whole blood using the
PureGene DNA Isolation Kit (Gentra Systems, Minneapolis,
MN). The three exons of the ARS gene were ampli¢ed by poly-
merase chain reaction (PCR) using the primers described pre-
viously (Fischer et al, 2001). For mutation detection, the PCR
products were sequenced using an Applied Biosystem 310 auto-
mated sequencing system.The PCR products were digested with
BspMI or DdeI at 371C for 3 h and analyzed on 1.5% agarose/
TBE minigels.
Haplotype analysis was performed using the following markers
from centromere to telomere: D8S1704, CNG002, CNG003,
D8S1751, D8S1836, D8S2334. Microsatellite markers £anking the
MdM locus at chromosome 8qter were chosen from the genetic
map at the Center for Medical Genetics, Marsh¢eld Medical
Research Foundation (http://www.research.marsh¢eldclinic.org/
genetics/), except for two markers CNG002 and CNG003 that
were obtained from a previous report (Fischer et al, 2001). The
primer sequences for PCR were obtained from the Genome
Database (http://www.gdb.org). The PCR products were resolved
on 6% nondenaturing polyacrylamide gels and visualized by
ethidium bromide staining.
In all families MdM was inherited in an autosomal recessive
manner (Fig 1). Family 1 is a large consanguineous family; how-
ever, a consanguinity loop was not found in families 2, 3, and 4.
All a¡ecteds exhibited transgrediens palmoplantar keratoderma
with hyperhidrosis, typical of MdM (Fig 2a), and a variety of
associated ¢ndings. A¡ecteds in family 1 had nail deformity,
knuckle pads, hyperkeratotic plaques on the knees, and high
arched palate. Individual V:14 also had retinitis pigmentosa. In fa-
mily 2 perioral erythema was observed as the associated ¢nding
with neither nail involvement nor hyperkeratotic plaques. In fa-
mily 3 nail dystrophy and in family 4 nail dystrophy and knuckle
pads were observed. In none of the a¡ecteds was brachydactly or
pseudoainhum noted.
In all three families, a homozygous C-to-T transition at nu-
cleotide 286 in exon 3, leading to a conversion of an arginine
residue (CGA) to a stop codon (TGA) at amino acid 96 was iden-
ti¢ed.Whereas the homozygous R96X mutation was observed in
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the proband, the parents displayed a heterozygous sequence
(Fig 2b). This mutation, designated R96X, creates a restriction
endonuclease site for the enzyme DdeI, which was used to con-
¢rm the mutation (Fig 2c). The sequence alterations found in
these families were not observed in 100 unrelated, una¡ected
Turkish controls.
To test whether these families shared the same haplotype at the
MdM locus, we performed haplotype analysis in three families
reported here and in one family we previously reported carrying
the same mutation, R96X, in theARS gene (family 2) (Ward et al,
2003). Ten a¡ected and seven una¡ected individuals were geno-
typed using six microsatellite markers spanning approximately
3.65 cM in the region. The disease gene is located between (or
telomeric to) the markers CNG003, D8S1751, and D8S1836. Re-
combination events in individualsV:6,V:9,V:14, andV:15 (family 1)
identi¢ed the same boundary as the one established previously
(Fischer et al, 2001). A¡ecteds in all four families showed homo-
zygosity at the MdM locus, whereas none of the una¡ecteds were
homozygous for both markers (Fig 1).
The ARS gene is predicted to consist of three translated
exons, and encodes a 103 amino acid protein, SLURP-1 (secreted
Ly-6/uPAR related protein 1). SLURP-1 belongs to the Ly-6/
uPAR family of proteins, which typically contain a highly con-
served pattern of disul¢de bridges (Adermann et al, 1999). R96X
mutation occurs in a CpG-containing arginine codon found in
exon 3 of the ARS gene. Deamination of CpG dinucleotides is
the most common mechanism underlying point mutations
in humans. This mutation results in a premature stop codon,
and thus the mutant allele is predicted to encode a truncated
protein that is missing the last eight amino acids. Although
R96X is towards the end of the protein, the truncated protein
lacks a cysteine implicated in one of the highly conserved disul-
¢de bridges.
To date, the nonsense mutation R96X has been identi¢ed in
three Croatian families and four Turkish families (including the
ones reported here) (Fischer et al, 2001; Ward et al, 2003). The
identi¢cation of recurrent mutations suggests that these may
be hot-spot mutations within the ARS gene, or alternatively a
common ancestral allele. To determine whether the mutation in
the Turkish population originated from a common ancestor, we
analyzed the R96X allele signatures in fourTurkish families. Our
results showed that all four families shared a common haplo-
type at the MdM locus, suggesting a founder e¡ect. Although the
unambiguous identical-by-descent sharing of this haplotype
cannot be demonstrated without the genotyping of certain
married-in individuals who were unavailable for this study, the
coincidental identical-by-state sharing of alleles in perfect concor-
dance with the segregation of the same point mutation in four
unrelated families seems highly improbable. Furthermore, the
markers used for haplotype analysis were highly polymorphic.
Of interest, three Croatian families with the mutation R96X
had been shown to share the same haplotypes at the MdM
locus (Fischer et al, 2001). It would be interesting to compare
the haplotypes of Croatian and Turkish families with R96X.
Future mutational analysis of additional families with MdM
from Turkey and neighboring countries will provide a better
Figure1. Pedigrees with MdM, showing haplotypes for markers at 8qter. The order of the markers is indicated in the upper right corner. The
disease-associated haplotype is highlighted.
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estimation of the frequency of the founder mutation within this
population.
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Figure 2. Clinical data and genetic analysis of families 1, 3, and 4 with MdM. (a) Keratodermawith transgrediens. (b) DNA sequence of exon 3 from
controls, heterozygous carriers, and homozygous a¡ected individuals. Encoding amino acid sequence is indicated on the wild-type sequence. (c) Restriction
endonuclease analysis with the enzyme DdeI. DdeI digestion cuts the 448 bp PCR product into 272, 90, 65, and 21 bp fragments on the wild-type allele. The
R96X mutation creates a new DdeI site at nucleotide 216 of the PCR product, and therefore digestion of the mutant allele results in fragments of 216, 90, 65,
56, and 21 bp.
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